Details for Patent: 10,188,637

Which drugs does patent 10,188,637 protect, and when does it expire?

Patent 10,188,637 protects ESBRIET and is included in one NDA.

This patent has eighteen patent family members in twelve countries.

Summary for Patent: 10,188,637

Patent landscape, scope, and claims:

Title:	Granulate formulation of 5-methyl-1-phenyl-2-(1H)-pyridone and method of making the same
Abstract:	The disclosure relates to granulate formulations of pirfenidone and methods of making such formulations.
Inventor(s):	Mujumdar; Siddharthya Krishnachandan (Basel, CH)
Assignee:	HOFFMANN-LA ROCHE INC. (Little Falls, NJ)
Application Number:	15/472,222
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,188,637
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound;

Drugs Protected by US Patent 10,188,637

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Genentech Inc	ESBRIET	pirfenidone	TABLET;ORAL	208780-001	Jan 11, 2017	AB	RX	Yes	No			Y
Genentech Inc	ESBRIET	pirfenidone	TABLET;ORAL	208780-002	Jan 11, 2017		DISCN	Yes	No			Y
Genentech Inc	ESBRIET	pirfenidone	TABLET;ORAL	208780-003	Jan 11, 2017	AB	RX	Yes	Yes			Y

International Family Members for US Patent 10,188,637

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	107990
Australia	2017241530
Australia	2022275529